Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | Prof. Bader’s highlights from EBMT 2019

Peter Bader • 10 Apr 2019
EBMT 2019
General Leukemia CAR-T

Peter Bader, MD, PhD, from Goethe University Frankfurt, Frankfurt, Germany, shares his thoughts on the most exciting data updates for the treatment of hematological malignancies. Speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany, Prof. Bader gives us a rundown on the fields of adult, pediatric, and cellular medicine.

More from Peter Bader

1:13
Transplantation in an evolving therapy landscape
Peter Bader • 26 Oct 2019
3:07
How will CAR-T cells help us cure Ph+ ALL?
Peter Bader • 25 Oct 2019
2:14
Mesenchymal stromal cells in the treatment of acute GVHD
Peter Bader • 25 Oct 2019
0:57
The aims of the EBMT Paediatric Disease Working Party
Peter Bader • 9 Sep 2016

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals